Furobe 40 Mg Tablet 40 mg TABLET
PDF Leaflet Revision Date: 02 February 2026
Clinical Summary
Quick overview from the medicine insert
Indication
Fluid retention and hypertension.
Dosage (summary)
Adults: 40 mg/day, may increase to 200 mg/day. Maintenance: 20-40 mg/day.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Aminoglycosides
- Lithium
- NSAIDs
- ACE inhibitors
Contraindications
- Hypersensitivity to furosemide
- Hypovolaemia
- Anuric renal failure
- Severe hypokalaemia
- Severe hyponatraemia
Common side effects
- Electrolyte disturbances
- Hypotension
- Nausea
- Dizziness
Counselling Points
- Take on an empty stomach
- Avoid dehydration
- Monitor blood pressure regularly
Serious warnings
- Monitor for electrolyte imbalances
- Risk of dehydration
- Caution in diabetes
Important Disclaimer
The Furobe 40 Mg Tablet 40 mg TABLET professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
